1. Home
  2. ABVX vs MTH Comparison

ABVX vs MTH Comparison

Compare ABVX & MTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • MTH
  • Stock Information
  • Founded
  • ABVX 2013
  • MTH 1985
  • Country
  • ABVX France
  • MTH United States
  • Employees
  • ABVX N/A
  • MTH N/A
  • Industry
  • ABVX
  • MTH Homebuilding
  • Sector
  • ABVX
  • MTH Consumer Discretionary
  • Exchange
  • ABVX Nasdaq
  • MTH Nasdaq
  • Market Cap
  • ABVX 5.3B
  • MTH 5.1B
  • IPO Year
  • ABVX N/A
  • MTH 1988
  • Fundamental
  • Price
  • ABVX $84.01
  • MTH $78.79
  • Analyst Decision
  • ABVX Strong Buy
  • MTH Buy
  • Analyst Count
  • ABVX 8
  • MTH 9
  • Target Price
  • ABVX $90.63
  • MTH $86.88
  • AVG Volume (30 Days)
  • ABVX 1.2M
  • MTH 939.5K
  • Earning Date
  • ABVX 08-11-2025
  • MTH 10-28-2025
  • Dividend Yield
  • ABVX N/A
  • MTH 2.17%
  • EPS Growth
  • ABVX N/A
  • MTH N/A
  • EPS
  • ABVX N/A
  • MTH 8.78
  • Revenue
  • ABVX $7,073,400.00
  • MTH $6,216,250,000.00
  • Revenue This Year
  • ABVX $25.23
  • MTH N/A
  • Revenue Next Year
  • ABVX N/A
  • MTH $6.59
  • P/E Ratio
  • ABVX N/A
  • MTH $9.03
  • Revenue Growth
  • ABVX N/A
  • MTH N/A
  • 52 Week Low
  • ABVX $4.77
  • MTH $59.27
  • 52 Week High
  • ABVX $92.91
  • MTH $106.99
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 67.94
  • MTH 53.63
  • Support Level
  • ABVX $82.72
  • MTH $77.85
  • Resistance Level
  • ABVX $91.30
  • MTH $84.74
  • Average True Range (ATR)
  • ABVX 3.62
  • MTH 2.04
  • MACD
  • ABVX -1.13
  • MTH -0.13
  • Stochastic Oscillator
  • ABVX 47.89
  • MTH 35.13

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

Share on Social Networks: